Inhibition of KDM6A/B with GSK-J4 has been shown to inhibit the proliferation of prostate cancer cell lines with castration-resistant prostate cancer cell lines, specifically those lacking the androgen receptor, exhibiting the highest sensitivity [37]. The gene discussed is AR; the disease is prostate carcinoma.